cp wire

CP Wire Articles


Inovio Pharmaceuticals, Inc. (NASDAQ:INO) and CEPI – the Coalition for Epidemic Preparedness Innovations – today announced a partnership under which Inovio will develop vaccine candidates... read more

Wed, 04/11/18 - 12:16 pm
CP Staff

  • Seladelpar maintains potent anti-cholestatic and anti-inflammatory activity and appears safe and well tolerated, with no drug-induced pruritus, through 26 weeks of treatment
  • ... read more
Wed, 04/11/18 - 11:18 am
CP Staff

Fujifilm Kyowa Kirin Biologics Co., Ltd. today announced the company will partner with Mylan N.V. (NASDAQ:MYL) to commercialize FKB327, a biosimilar to Humira (adalimumab) developed by Fujifilm... read more

Wed, 04/11/18 - 09:32 am
CP Staff

Nektar Therapeutics (Nasdaq: NKTR) today announced that it has initiated dosing patients in the Phase 1/2 REVEAL clinical study evaluating the efficacy and safety of the combination of... read more

Wed, 04/11/18 - 09:18 am
CP Staff

Quadrant Biosciences announced today the execution of three licensing agreements with SUNY Upstate Medical University and Penn State University for the global commercialization of epigenetic... read more

Tue, 04/10/18 - 10:03 pm
CP Staff

Pfizer announced today that the independent Data Monitoring Committee for the Phase 3 ATLAS trial evaluating Inlyta The study failing to demonstrate a clear improvement in the primary endpoint of... read more

Tue, 04/10/18 - 02:44 pm
CP Staff

Mylan and Mapi Pharma announced today that the two companies will partner on the development and commercialization of GA Depot, a long-acting Glatiramer Acetate product. Mylan is acquiring global... read more

Tue, 04/10/18 - 09:50 am
CP Staff

Inflammatix announced today that it has been named a finalist in Fast Company's 2018 World Changing Ideas Awards for its novel HostDx tests, which read the immune system to tackle the global... read more

Tue, 04/10/18 - 09:27 am
admin


AbbVie and Neurocrine announced notification by the U.S. Food and Drug Administration (FDA) that it requires extended time to review additional information regarding the results of liver... read more

Tue, 04/10/18 - 09:14 am
admin

vTv (Nasdaq:VTVT) today announced that results from Part A of the Company’s Phase 3 STEADFAST study of the investigational medication azeliragon in people with mild Alzheimer’s disease did not... read more

Mon, 04/9/18 - 08:21 pm
admin

Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report further data analysis from its successfully completed Phase 2 clinical... read more

Mon, 04/9/18 - 03:14 pm
admin

Second Genome, Inc., a leader in the development of novel medicines derived from the human microbiome, today announced the presentation of preclinical data and results from a Phase 1 study in... read more

Mon, 04/9/18 - 03:12 pm
admin

Researchers from the University of Illinois at Chicago and Nosopharm, a biotechnology company based in Lyon, France, are part of an international team reporting on the discovery of a new class of... read more

Mon, 04/9/18 - 11:01 am
CP Staff

The article discusses the concern over the number of deaths (244) and other adverse events linked to nuplazid. The drug was approved in April of 2016 as a much needed treatment for Parkinson's... read more

Mon, 04/9/18 - 09:42 am
CP Staff

BioCardia®, Inc., [OTC: BCDA] a leader in cardiovascular regenerative medicine, today announced the publication of the Phase III CardiAMP Heart Failure Trial design paper in the American Heart... read more

Mon, 04/9/18 - 09:13 am
CP Staff

Clovis Oncology, Inc. (NASDAQ:CLVS) today announced that the U.S. Food and Drug Administration (FDA) has approved Rubraca® (rucaparib) tablets for the maintenance treatment of adult patients with... read more

Fri, 04/6/18 - 02:41 pm
CP Staff

EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG), today announced completion of patient enrollment for the pivotal Phase 3 clinical study of its EGP-437 combination product for the treatment of non-... read more

Fri, 04/6/18 - 09:42 am
CP Staff

Results from a recent clinical trial to treat lung cancer show that a novel immunotherapy combination is surprisingly effective at controlling the disease's progression. The study, published April... read more

Thu, 04/5/18 - 11:40 pm
CP Staff

VisionGate, a clinical stage oncology pharmaceutical and diagnostics company, is pleased to announce today the advancement of its breakthrough technology Cell-CT platform.  The first shipment of... read more

Thu, 04/5/18 - 07:39 pm
CP Staff

Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases,... read more

Thu, 04/5/18 - 03:50 pm
CP Staff

Pages